8th AIDS Seminar in KUMAMOTO
   第8回熊本エイズセミナープログラム

■ 14 September

Session I  Antiretroviral drugs


Yasuhiro Koh (Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan)
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization

Hirokazu Tamamura (Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan)
Development of anti-HIV agents based on chemokine receptor CXCR4 antagonists

Wataru Sugiura (National Institute of Infectious Diseases, Tokyo, Japan)
Genetic and structural interferences between protease inhibitor resistant mutations and Gag polymorphisms---their consequence in drug resistance selection and acquisition---

Ladislau C. Kovari (Wayne State University School of Medicne, Detroit, USA)
Structure-function studies of HIV-1 protease drug resistance

Session II  Immune responses and Vacccine I

Junji Shibata (Center for AIDS Research, Kumamoto University, Kumamoto, Japan)
The single mutation in V2 domain affects quaternary structure of trimer gp120 and dramatically increases the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralizing antibodies

Takamasa Ueno (Center for AIDS Research, Kumamoto University, Kumamoto, Japan)
CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef

Marcus Altfeld (Harvard Medical School, Boston, USA)
HIV-1-specific CD8+ T cell responses in Acute HIV-1 Infection


Poster Session II

11:10-12:00



Lunch(on your own)
12:00-12:50


Session III  Immune responses and vaccine II
12:50-14:10
Chair: Masafumi Takiguchi and Hiroyuki Gatanaga

12:50-13:05 Yuka Kawashima (Center for AIDS research, Kumamoto University, Kumamoto, Japan)
Control of HIV-1 replication by HIV-1-specific CTL in HLA-B*51+ long-term non progressors

13:05-13:30 Yasuko Tsunetsugu-Yokota (National Institute of Infectious Diseases, Tokyo, Japan)
Immune control of HIV-1 by restoring HIV-specific CD4+ T-cell function: a vaccine strategy against chronic HIV/SIV infection

13:30-14:10 Tomas Hanke (University of Oxford, Oxford, U.K)
Development of HIV-1 vaccines inducing protective T cell responses




Session IV  Viral replication and pathogenesis
14:25-16:00
Chair: Atsushi Koito and Tatsuyoshi Kawamura

14:25-14:50 Tatsuyoshi Kawamura (Faculty of medicine, University of Yamanashi, Yamanashi, Japan)
TLR2 activation augments HIV replication in Langerhans cells; implications for sexual transmission of HIV

14:50-15:15 Akifumi Takaori (Graduate School of Medicine, Kyoto University, Kyoto, Japan)
Escape of retroviruses from antiviral host defense by APOBEC3

15:15-15:40 Jun-ichi Sakuragi (Research Institute for Microbial Diseases, Osaka University, Osaka, Japan)
HIV-1 genome RNA dimerization and its roles on viral replication

15:40-16:00 Shinya Suzu (Center for AIDS Research, Kumamoto University, Kumamoto, Japan)
Spatial regulation of macrophage-specific tyrosine kinases Hck and M-CSF receptor by HIV-1 Nef
     
 Back
  ← 13 Sep.
Poster Session